Benefit from revascularization after thrombectomy according to FLAIR vascular hyperintensities-DWI mismatch.


Journal

European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774

Informations de publication

Date de publication:
Oct 2019
Historique:
received: 10 10 2018
accepted: 08 02 2019
revised: 28 01 2019
pubmed: 25 3 2019
medline: 18 12 2019
entrez: 24 3 2019
Statut: ppublish

Résumé

We tested whether FLAIR vascular hyperintensities (FVH)-DWI mismatch could identify candidates for thrombectomy most likely to benefit from revascularization. We retrospectively reviewed 100 patients with proximal MCA occlusion from 18 stroke centers randomized in the IV-thrombolysis plus mechanical thrombectomy arm of the THRACE trial (2010-2015). We tested the associations between successful revascularization on digital subtraction angiography (modified Thrombolysis in Cerebral Infarction 2b/3) and 3-month favorable outcome (modified Rankin Scale score ≤ 2), stratified on FVH-DWI mismatch status, with secondary analyses adjusted on National Institutes of Health Stroke Scale (NIHSS) and DWI lesion volume. FVH-DWI mismatch was present in 79% of patients, with a similar prevalence at 1.5 T (80%) and 3 T (78%). Successful revascularization (74%) was more frequent in patients with FVH-DWI mismatch (63/79, 80%) than in patients without (11/21, 52%), p = 0.01. The OR of favorable outcome for revascularization were 15.05 (95% CI 3.12-72.61, p < 0.001) in patients with FVH-DWI mismatch and 0.83 (95% CI 0.15-4.64, p = 0.84) in patients without FVH-DWI mismatch (p = 0.011 for interaction). Similar results were observed after adjustment for NIHSS (OR = 12.73 [95% CI 2.69-60.41, p = 0.001] and 0.96 [95% CI 0.15-6.30, p = 0.96]) or for DWI volume (OR = 12.37 [95% CI 2.76-55.44, p = 0.001] and 0.91 [95% CI 0.16-5.33, p = 0.92]) in patients with and without FVH-DWI mismatch, respectively. The FVH-DWI mismatch identifies patients likeliest to benefit from revascularization, irrespective of initial DWI lesion volume and clinical stroke severity, and could serve as a useful surrogate marker for penumbral evaluation. • The FVH-DWI mismatch, defined by FLAIR vascular hyperintensities (FVH) located beyond the boundaries of the DWI lesion, is associated with large penumbra. • Among stroke patients with proximal middle cerebral artery occlusion referred for thrombectomy, those with FVH-DWI mismatch are most likely to benefit from revascularization. • FVH-DWI mismatch provides an alternative to PWI-DWI mismatch in order to select patients who are candidates for thrombectomy.

Identifiants

pubmed: 30903341
doi: 10.1007/s00330-019-06094-y
pii: 10.1007/s00330-019-06094-y
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

5567-5576

Références

Stroke. 1992 May;23(5):646-52
pubmed: 1579960
Front Neurol. 2017 Jun 19;8:272
pubmed: 28674513
Stroke. 2012 Nov;43(11):2986-91
pubmed: 22996954
Cerebrovasc Dis. 2016;41(1-2):27-34
pubmed: 26579719
Cerebrovasc Dis. 2012;34(5-6):376-84
pubmed: 23207238
Stroke. 2018 Mar;49(3):750-753
pubmed: 29382803
AJNR Am J Neuroradiol. 2015 Feb;36(2):269-74
pubmed: 25190202
AJNR Am J Neuroradiol. 2009 Mar;30(3):564-8
pubmed: 19022866
N Engl J Med. 2018 Jan 4;378(1):11-21
pubmed: 29129157
Stroke. 2018 Mar;49(3):e46-e110
pubmed: 29367334
Arch Neurol. 2012 Nov;69(11):1462-8
pubmed: 22893218
Stroke. 2014 Jul;45(7):2036-40
pubmed: 24876081
Stroke. 2016 Feb;47(2):424-7
pubmed: 26732567
PLoS One. 2015 Sep 01;10(9):e0137292
pubmed: 26327519
J Stroke. 2017 May;19(2):121-130
pubmed: 28592779
Eur Neurol. 2012;68(4):214-20
pubmed: 22964844
N Engl J Med. 2018 Feb 22;378(8):708-718
pubmed: 29364767
J Neurol Neurosurg Psychiatry. 2018 Sep;89(9):910-917
pubmed: 29519899
Neurology. 2009 Mar 31;72(13):1134-9
pubmed: 19211928
J Neurol Neurosurg Psychiatry. 2008 Jun;79(6):625-9
pubmed: 18077482
AJNR Am J Neuroradiol. 2018 Jan;39(1):77-83
pubmed: 29074634
J Clin Epidemiol. 1995 Dec;48(12):1503-10
pubmed: 8543964
Radiology. 2015 Mar;274(3):851-8
pubmed: 25559232
Lancet Neurol. 2016 Oct;15(11):1138-47
pubmed: 27567239
Stroke. 2018 Mar;49(3):675-681
pubmed: 29459394
Stroke. 2016 Nov;47(11):2763-2769
pubmed: 27659851
Neurology. 2004 Jun 22;62(12):2187-92
pubmed: 15210880
Stroke. 2011 Mar;42(3):693-9
pubmed: 21233472
Eur J Radiol. 2011 Dec;80(3):786-91
pubmed: 21067881
AJNR Am J Neuroradiol. 2011 Nov-Dec;32(10):1771-5
pubmed: 21051516
Lancet. 2016 Apr 23;387(10029):1723-31
pubmed: 26898852
AJNR Am J Neuroradiol. 2008 Mar;29(3):582-7
pubmed: 18337393

Auteurs

Laurence Legrand (L)

Department of Neuroradiology, INSERM U1266, Sainte-Anne Hospital, Paris Descartes University, Paris, France.

Guillaume Turc (G)

Department of Neurology, INSERM U1266, Sainte-Anne Hospital, Paris Descartes University, Paris, France.

Myriam Edjlali (M)

Department of Neuroradiology, INSERM U1266, Sainte-Anne Hospital, Paris Descartes University, Paris, France.

Marine Beaumont (M)

Clinical Investigation Centre-Innovative Technology, INSERM U1254, Lorraine University, Lorraine, France.

Vincent Gautheron (V)

Department of Neuroradiology, INSERM U1266, Sainte-Anne Hospital, Paris Descartes University, Paris, France.

Wagih Ben Hassen (W)

Department of Neuroradiology, INSERM U1266, Sainte-Anne Hospital, Paris Descartes University, Paris, France.

Sylvain Charron (S)

Department of Neuroradiology, INSERM U1266, Sainte-Anne Hospital, Paris Descartes University, Paris, France.

Denis Trystram (D)

Department of Neuroradiology, INSERM U1266, Sainte-Anne Hospital, Paris Descartes University, Paris, France.

Grégoire Boulouis (G)

Department of Neuroradiology, INSERM U1266, Sainte-Anne Hospital, Paris Descartes University, Paris, France.

Romain Bourcier (R)

Department of Neuroradiology, CHU Nantes, Nantes, France.

Joseph Benzakoun (J)

Department of Neuroradiology, INSERM U1266, Sainte-Anne Hospital, Paris Descartes University, Paris, France.

Olivier Naggara (O)

Department of Neuroradiology, INSERM U1266, Sainte-Anne Hospital, Paris Descartes University, Paris, France.

Frédéric Clarençon (F)

Department of Neuroradiology, Pitié-Salpêtrière Hospital, Paris, France.

Serge Bracard (S)

Department of Neuroradiology, CHRU Nancy, Nancy, France.

Catherine Oppenheim (C)

Department of Neuroradiology, INSERM U1266, Sainte-Anne Hospital, Paris Descartes University, Paris, France. c.oppenheim@ch-sainte-anne.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH